Stockreport

Marker Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates [Yahoo! Finance]

Marker Therapeutics, Inc.  (MRKR) 
Last marker therapeutics, inc. earnings: 11/12 04:01 pm Check Earnings Report
PDF Study participant with Non-Hodgkin's Lymphoma who relapsed within 90 days of anti-CD19 CAR T cell therapy remains in complete response nine months after MT-601 treatmen [Read more]